|
1
|
Djulbegovic M, Beyth RJ, Neuberger MM,
Stoffs TL, Vieweg J, Djulbegovic B and Dahm P: Screening for
prostate cancer: Systematic review and meta-analysis of randomised
controlled trials. Bmj. 341:c45432010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Henry RY and O'Mahony D: Treatment of
prostate cancer. J Clin Pharm Ther. 24:93–102. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lozano R, Naghavi M, Foreman K, Lim S,
Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et
al: Global and regional mortality from 235 causes of death for 20
age groups in 1990 and 2010: A systematic analysis for the global
burden of disease study 2010. Lancet. 380:2095–2128. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abate-Shen C and Shen MM: Molecular
genetics of prostate cancer. Genes Dev. 14:2410–2434. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hafeez BB, Zhong W, Fischer JW, Mustafa A,
Shi X, Meske L, Hong H, Cai W, Havighurst T, Kim K and Verma AK:
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived
1,4-naphthoquinone, inhibits growth and metastasis of human
prostate cancer PC-3M-luciferase cells in an orthotopic xenograft
mouse model. Mol Oncol. 7:428–439. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pani G, Galeotti T and Chiarugi P:
Metastasis: Cancer cell's escape from oxidative stress. Cancer
Metastasis Rev. 29:351–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spano D, Heck C, De Antonellis P,
Christofori G and Zollo M: Molecular networks that regulate cancer
metastasis. Semin Cancer Biol. 22:234–249. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coso S and Williams ED: Prostate Cancer
Lymph Node Metastasis. 2009.
|
|
10
|
Woollard DJ, Opeskin K, Coso S, Wu D,
Baldwin ME and Williams ED: Differential expression of VEGF ligands
and receptors in prostate cancer. Prostate. 73:563–572. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW,
Sahin A, Brinkley BR and Sen S: Tumour amplified kinase STK15/BTAK
induces centrosome amplification, aneuploidy and transformation.
Nat Genet. 20:189–193. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Grubb RL, Deng J, Pinto PA, Mohler JL,
Chinnaiyan A, Rubin M, Linehan WM, Liotta LA, Petricoin EF and
Wulfkuhle JD: Pathway biomarker profiling of localized and
metastatic human prostate cancer reveal metastatic and prognostic
signatures. J Proteome Res. 8:3044–3054. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Watahiki A and Wang Y, Morris J, Dennis K,
O'Dwyer HM, Gleave M, Gout PW and Wang Y: MicroRNAs associated with
metastatic prostate cancer. PLoS One. 6:e249502011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Prensner JR, Rubin MA, Wei JT and
Chinnaiyan AM: Beyond PSA: The next generation of prostate cancer
biomarkers. Sci Transl Med. 4:127rv32012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JH, Dhanasekaran SM, Prensner JR, Cao
X, Robinson D, Kalyana-Sundaram S, Huang C, Shankar S, Jing X, Iyer
M, et al: Deep sequencing reveals distinct patterns of DNA
methylation in prostate cancer. Genome Res. 21:1028–1041. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lopez-Romero P: AgiMicroRna: Processing
and Differential Expression Analysis of Agilent microRNA chips. R
package version 2.24.0. 2016.
|
|
18
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Royal Stat Society Series B (Methodological).
57:289–300. 1995.
|
|
20
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID bioinformatics resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35:W169–W175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Keshava Prasad TS, Goel R, Kandasamy K,
Keerthikumar S, Kumar S, Mathivanan S, Telikicherla D, Raju R,
Shafreen B, Venugopal A, et al: Human protein reference
database-2009 update. Nucleic Acids Res. 37(Database issue):
D767–D772. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chatr-aryamontri A, Breitkreutz BJ,
Heinicke S, Boucher L, Winter A, Stark C, Nixon J, Ramage L, Kolas
N, O'Donnell L, et al: The BioGRID interaction database: 2013
update. Nucleic Acids Res. 41(Database issue): D816–D823.
2013.PubMed/NCBI
|
|
23
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41(Database issue): D808–D815. 2013.PubMed/NCBI
|
|
24
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee KC, Bradley DA, Hussain M, Meyer CR,
Chenevert TL, Jacobson JA, Johnson TD, Galban CJ, Rehemtulla A,
Pienta KJ and Ross BD: A feasibility study evaluating the
functional diffusion map as a predictive imaging biomarker for
detection of treatment response in a patient with metastatic
prostate cancer to the bone. Neoplasia. 9:1003–1011. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Perabo F, Von Löw E, Ellinger J, Von
Rücker A, Müller S and Bastian P: Soy isoflavone genistein in
prevention and treatment of prostate cancer. Prostate Cancer
Prostatic Dis. 11:6–12. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen MM and Abate-Shen C: Molecular
genetics of prostate cancer: New prospects for old challenges.
Genes Dev. 24:1967–2000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith TG, Robbins PA and Ratcliffe PJ: The
human side of hypoxia-inducible factor. Br J Haematol. 141:325–334.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Erler JT and Giaccia AJ: Lysyl oxidase
mediates hypoxic control of metastasis. Cancer Res. 66:10238–10241.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bae K, Dai Y, Vieweg J and Siemann D:
Hypoxia increases the expression of stem-cell markers and promotes
cell invasion in prostate cancer cells. Cancer Res. 71:4852011.
View Article : Google Scholar
|
|
32
|
Chen YF, Chen YT, Chiu WT and Shen MR:
Remodeling of calcium signaling in tumor progression. J Biomed Sci.
20:232013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rizzuto R and Pozzan T: When calcium goes
wrong: Genetic alterations of a ubiquitous signaling route. Nat
Genet. 34:135–141. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Parekh AB: Store-operated CRAC channels:
Function in health and disease. Nat Rev Drug Discov. 9:399–410.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Monteith GR, Davis FM and Roberts-Thomson
SJ: Calcium channels and pumps in cancer: Changes and consequences.
J Biol Chem. 287:31666–31673. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Prevarskaya N, Skryma R and Shuba Y:
Calcium in tumour metastasis: New roles for known actors. Nat Rev
Cancer. 11:609–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang ZH, Wang XH, Wang HP and Hu LQ:
Effects of TRPM8 on the proliferation and motility of prostate
cancer PC-3 cells. Asian J Androl. 11:157–165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gkika D, Flourakis M, Lemonnier L and
Prevarskaya N: PSA reduces prostate cancer cell motility by
stimulating TRPM8 activity and plasma membrane expression.
Oncogene. 29:4611–4616. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Monet M, Lehen'kyi V, Gackiere F, Firlej
V, Vandenberghe M, Roudbaraki M, Gkika D, Pourtier A, Bidaux G,
Slomianny C, et al: Role of cationic channel TRPV2 in promoting
prostate cancer migration and progression to androgen resistance.
Cancer Res. 70:1225–1235. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Littman DR: The structure of the CD4 and
CD8 genes. Annu Rev Immunol. 5:561–584. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Foti M, Phelouzat MA, Holm A, Rasmusson BJ
and Carpentier JL: p56Lck anchors CD4 to distinct microdomains on
microvilli. Proc Natl Acad Sci USA. 99:pp. 2008–2013. 2002;
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
DeNardo DG, Barreto JB, Andreu P, Vasquez
L, Tawfik D, Kolhatkar N and Coussens LM: CD4(+) T cells regulate
pulmonary metastasis of mammary carcinomas by enhancing protumor
properties of macrophages. Cancer Cell. 16:91–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC,
Jin J and Chang C: Infiltrating T cells promote prostate cancer
metastasis via modulation of FGF11->miRNA-541->androgen
receptor (AR)->MMP9 signaling. Mol Oncol. 9:44–57. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li DM and Feng YM: Signaling mechanism of
cell adhesion molecules in breast cancer metastasis: Potential
therapeutic targets. Breast Cancer Res Trea. 128:7–21. 2011.
View Article : Google Scholar
|
|
46
|
Hawash IY, Hu XE, Adal A, Cassady JM,
Geahlen RL and Harrison ML: The oxygen-substituted palmitic acid
analogue, 13-oxypalmitic acid, inhibits Lck localization to lipid
rafts and T cell signaling. Biochim Biophys Acta. 1589:140–150.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vaday GG, Peehl DM, Kadam PA and Lawrence
DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer.
Prostate. 66:124–134. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Moldovan GL, Pfander B and Jentsch S:
PCNA, the maestro of the replication fork. Cell. 129:665–679. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhao H, Lo YH, Ma L, Waltz SE, Gray JK,
Hung MC and Wang SC: Targeting tyrosine phosphorylation of PCNA
inhibits prostate cancer growth. Mol Cancer Ther. 10:29–36. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jiaping P: Abstract B104: Expressions of
PCNA in triple negative breast cancers and Their clinical
significance. Cancer Prev Res. 5:B1042012. View Article : Google Scholar
|
|
51
|
Malumbres M and Barbacid M: Cell cycle,
CDKs and cancer: A changing paradigm. Nat Rev Cancer. 9:153–166.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Altieri DC: Survivin, cancer networks and
pathway-directed drug discovery. Nat Rev Cancer. 8:61–70. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang H, Zhang X, Wang L, Zheng G, Du L,
Yang Y, Dong Z, Liu Y, Qu A and Wang C: Investigation of cell free
BIRC5 mRNA as a serum diagnostic and prognostic biomarker for
colorectal cancer. J Surg Oncol. 109:574–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vitale I, Galluzzi L, Senovilla L, Criollo
A, Jemaà M, Castedo M and Kroemer G: Illicit survival of cancer
cells during polyploidization and depolyploidization. Cell Death
Differ. 18:1403–1413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kwon M, Godinho SA, Chandhok NS, Ganem NJ,
Azioune A, Thery M and Pellman D: Mechanisms to suppress multipolar
divisions in cancer cells with extra centrosomes. Genes Dev.
22:2189–2203. 2008. View Article : Google Scholar : PubMed/NCBI
|
